These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Calcineurin inhibitor sparing immunosuppressive regimens in kidney allograft recipients. Baczkowska T; Durlik M Pol Arch Med Wewn; 2009 May; 119(5):318-25. PubMed ID: 19579814 [TBL] [Abstract][Full Text] [Related]
4. Calcineurin inhibitor-free protocols: risks and benefits. Barbari AG; Stephan AG; Masri MA Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):1-23. PubMed ID: 17237886 [TBL] [Abstract][Full Text] [Related]
5. Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan. Mao PC; Lee EK; Tseng PL Transplant Proc; 2012 Jan; 44(1):185-9. PubMed ID: 22310611 [TBL] [Abstract][Full Text] [Related]
6. Current concepts and perspectives of immunosuppression in organ transplantation. Scherer MN; Banas B; Mantouvalou K; Schnitzbauer A; Obed A; Krämer BK; Schlitt HJ Langenbecks Arch Surg; 2007 Sep; 392(5):511-23. PubMed ID: 17450373 [TBL] [Abstract][Full Text] [Related]
7. Treatment strategies in pediatric solid organ transplant recipients with calcineurin inhibitor-induced nephrotoxicity. Tönshoff B; Höcker B Pediatr Transplant; 2006 Sep; 10(6):721-9. PubMed ID: 16911497 [TBL] [Abstract][Full Text] [Related]
8. Trends in maintenance immunosuppressive drugs used in taiwanese kidney transplant recipients: an analysis of the national health insurance research database. Tsai SF; Cheng CY; Shu KH; Wu MJ Transplant Proc; 2012 Jan; 44(1):190-2. PubMed ID: 22310612 [TBL] [Abstract][Full Text] [Related]
9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes. Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960 [TBL] [Abstract][Full Text] [Related]
11. A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology. Stevens RB; Foster KW; Miles CD; Kalil AC; Florescu DF; Sandoz JP; Rigley TH; Malik T; Wrenshall LE PLoS One; 2015; 10(10):e0139247. PubMed ID: 26465152 [TBL] [Abstract][Full Text] [Related]
12. Steroid- and calcineurin inhibitor free immunosuppression in kidney transplantation: state of the art and future developments. Giessing M; Fuller TF; Tuellmann M; Slowinski T; Budde K; Liefeldt L World J Urol; 2007 Jun; 25(3):325-32. PubMed ID: 17333201 [TBL] [Abstract][Full Text] [Related]
13. Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. Tanriover B; Zhang S; MacConmara M; Gao A; Sandikci B; Ayvaci MU; Mete M; Tsapepas D; Rajora N; Mohan P; Lakhia R; Lu CY; Vazquez M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1041-9. PubMed ID: 25979971 [TBL] [Abstract][Full Text] [Related]
14. The need for minimization strategies: current problems of immunosuppression. Bamoulid J; Staeck O; Halleck F; Khadzhynov D; Brakemeier S; Dürr M; Budde K Transpl Int; 2015 Aug; 28(8):891-900. PubMed ID: 25752992 [TBL] [Abstract][Full Text] [Related]
15. High incidence of rejection episodes and poor tolerance of sirolimus in a protocol with early steroid withdrawal and calcineurin inhibitor-free maintenance therapy in renal transplantation: experiences of a randomized prospective single-center study. Burkhalter F; Oettl T; Descoeudres B; Bachmann A; Guerke L; Mihatsch MJ; Dickenmann M; Steiger J Transplant Proc; 2012 Dec; 44(10):2961-5. PubMed ID: 23195006 [TBL] [Abstract][Full Text] [Related]
16. The impact of age on patient tolerance of mycophenolate following kidney transplantation. Rennie TJW; Petrie M; Metcalfe W; Walbaum D; Joss N; Barton E; Marson L; Clancy MJ; Henderson L; Traynor JP; Geddes CG; Phelan PJ Nephrology (Carlton); 2020 Jul; 25(7):566-574. PubMed ID: 32323461 [TBL] [Abstract][Full Text] [Related]
17. Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity. Flechner SM; Kobashigawa J; Klintmalm G Clin Transplant; 2008; 22(1):1-15. PubMed ID: 18217899 [TBL] [Abstract][Full Text] [Related]
19. Immunosuppression in live-related donor renal transplantation. Iman A; Rao M; Juneja R; Jacob CK Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322 [TBL] [Abstract][Full Text] [Related]